![Marino Garcia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marino Garcia
Vorstandsvorsitzender bei DIANTHUS THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Marino Garcia
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 22 | |
Aspreva Pharmaceuticals Corp.
![]() Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada.
21
| Extinct | Pharmaceuticals: Major | 21 |
Public Company | Pharmaceuticals: Major | 21 | |
Subsidiary | Pharmaceuticals: Major | 12 | |
Dianthus Therapeutics, Inc. (Massachusetts)
![]() Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA.
4
| Subsidiary | Biotechnology | 4 |
Aptalis Pharma Canada ULC
![]() Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada.
1
| Extinct | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marino Garcia
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
University of British Columbia | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Corporate Secretary Corporate Officer/Principal | |
OKYO PHARMA LIMITED | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Investor Relations Contact | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Human Resources Officer | |
EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
University of Copenhagen | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
GALENICA AG | Medical Distributors | Chairman Director of Finance/CFO Chairman | |
McGill University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
RADIUS HEALTH, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
Vifor Pharma Management AG
![]() Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of London | College/University | Doctorate Degree Undergraduate Degree | |
University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
RALLYBIO CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Copenhagen Business School | College/University | Graduate Degree Masters Business Admin | |
Michael Smith Foundation for Health Research
![]() Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
viDA Therapeutics, Inc.
![]() viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Human Resources Officer | |
Qu Biologics, Inc.
![]() Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Gilead Colorado, Inc.
![]() Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member Director of Finance/CFO | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Viridian LLC
![]() Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Executive Officer Founder | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Baroda | College/University | Doctorate Degree Doctorate Degree | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member Director/Board Member | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Director/Board Member |
Statistik
International
Vereinigte Staaten | 24 |
Kanada | 13 |
Vereinigtes Königreich | 6 |
Schweiz | 5 |
Dänemark | 3 |
Sektoral
Health Technology | 37 |
Consumer Services | 10 |
Retail Trade | 2 |
Commercial Services | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 353 |
Corporate Officer/Principal | 162 |
Independent Dir/Board Member | 119 |
Chief Executive Officer | 63 |
Chairman | 58 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Lonnie Moulder | 31 |
Catherine Moukheibir | 29 |
Ron Hunt | 29 |
Michael Hayden | 27 |
R. MacKay-Dunn | 26 |
Richard Glickman | 26 |
Jeffrey Berkowitz | 26 |
Alison Lawton | 25 |
Anne McGeorge | 25 |
George Milne | 24 |
Kirk Calhoun | 23 |
Rosemary Crane | 23 |
Leonard Kruimer | 22 |
Bill Hunter | 22 |
Julia G. Levy | 22 |
- Börse
- Insiders
- Marino Garcia
- Unternehmensverbindungen